Keiji Hirai

32PUBLICATIONS
22CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Clinical nutritionPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Systems physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 18, 2025
Efficacy of dapagliflozin on uric acid in patients with moderate-to-severe chronic kidney disease.

Katsunori Yanai, Keiji Hirai, Taisuke Kitano

|Oct 21, 2024
Efficacy and Safety of Adding Empagliflozin to Liraglutide on Renal Function in Patients with Advanced-Stage Type 2 Diabetic Kidney Disease: A Randomized Controlled Trial.

Kae Sunagawa, Keiji Hirai, Sumito Sunagawa

|Jul 27, 2024
Approximation of Glomerular Filtration Rate after 1 Year Using Annual Medical Examination Data.

Keiji Hirai, Taisuke Kitano, Keiji Nakayama

|May 22, 2024
Anti-SARS-CoV-2 Spike Antibody Response to the Fourth Dose of BNT162b2 mRNA COVID-19 Vaccine and Associated Factors in Japanese Hemodialysis Patients.

Keiji Hirai, Masako Shimotashiro, Toshiaki Okumura

Pageof 6